GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening | MicrobiomeTrials← Back to trialsNCT07668193
GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2027-11
Enrollment target: 1,200 participants Other microbiome trials you might be interested in
GlaucomaGlaucoma, Suspect
Goldmann Applanation Tonometry (GAT) is considered the clinical gold standard for eye pressure measurements and yet it i…
Durham, United StatesCompleted May 31, 2024
Glaucoma
Open-angle glaucoma is the most common type of glaucoma, a disease that damages the nerves in the eye and can lead to vi…
Boston, United StatesEst. completion Jul 31, 2030
Recruiting
Glaucoma, Open-anglePrimary Open Angle Glaucoma (POAG)
The goal of this clinical trial is to learn whether a high-dose vitamin B3 supplement called nicotinamide can protect re…
Chicago, United StatesEst. completion Sep 30, 2029